Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOW-PROMOTE: Intensive Lipid-lowering in Stable Chest Pain
NCT04737408Phase 3Unknown
- Start
- May 2020
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin, ezetimibe in coronary artery disease (CAD). Status: unknown.
02
Drugs
rosuvastatinezetimibe
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04737408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04737408.